Lunacalcipol | m-entrepreneurship.com

Product Name :
Lunacalcipol

Search keywords :
Cytochrome P450 24A1

drugId :
null

Target Vo:
Cytochrome P450 24A1

Target Vo Short Name :
CYP24A1

Moa_Name:
Cytochrome P450 24A1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Opko Health Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hyperparathyroidism, Secondary

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Zigakibart Epigenetic Reader Domain
Albumin Rabbit mAb medchemexpress
CD90/Thy-1 Antibody: CD90/Thy-1 Antibody is an unconjugated, approximately 12 kDa, rabbit-derived, anti-CD90/Thy-1 polyclonal antibody. CD90/Thy-1 Antibody can be used for: WB, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, horse, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts